AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Media Release: Bioniche Life Sciences IncAAP MEDIANET BIONICHE LIFE SCIENCES I.

Asia Africa Intelligence Wire

| July 12, 2005 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From MediaNet Press Release Wire)

Bioniche Reports Positive News from Betac(TM) Product Recall Investigation BELLEVILLE, July 12 /PRNewswire-AsiaNet/ -- - Betac does not present significant risk to humans; potency and pH of product not affected - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that an investigation into its injectable ascorbic acid product, Betac(TM), has shown that the product is free of microbial contamination. Betac was the subject of a voluntary Class 1 recall last month after one-third of the product released to the market was found to contain a small amount of …

Related articles from newspapers, magazines, journals, and more
Bioniche Life Sciences Inc. Nomme Un President Independant a la Tete De Son...
News wire article from: The America's Intelligence Wire July 30, 2012 700+ words
Bioniche Life Sciences Inc. Appoints an Independent Chairman of Its Board of...
News wire article from: The America's Intelligence Wire July 30, 2012 700+ words
Bioniche Life Sciences Inc. Moves Closer to Market Launch of Immunocidin(TM)
News wire article from: The America's Intelligence Wire July 23, 2012 700+ words
Bioniche Life Sciences Inc. Conclut Une Entente De Distribution Pour Des...
News wire article from: The America's Intelligence Wire March 22, 2012 700+ words
Bioniche Life Sciences Inc. Sur le Point De Commercialiser Immunocidin(MC)
News wire article from: The America's Intelligence Wire July 23, 2012 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily